MS

Morgan Stanley
D

MS

Arincen79/100B

Morgan Stanley free cash flow 1989–2026

Morgan Stanley's free cash flow in Q3 FY2026, the three months to 30 September 2026, was -46.97B USD, against -4.05B USD on the same quarter a year before. Morgan Stanley's free cash flow in fiscal year 2025 was 46.10B USD, against -2.10B USD on the year before.

Last updated 8 Nov 2026 · Next report 14 Jan 2027

Free cash flow

Free cash flow · +35.0% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 2026———-58.28B——
FY202531 Dec 202546.10B—69.88%49.00B-2.90B28.94
FY202431 Dec 2024-2.10B—-3.64%1.36B-3.46B-1.30
FY202331 Dec 2023-36.95B—-72.92%-33.54B-3.41B-22.45
FY202231 Dec 2022-9.48B-129.92%-18.87%-6.40B-3.08B-5.53
FY202131 Dec 202131.66B—56.13%33.97B-2.31B17.45
FY202031 Dec 2020-26.68B-168.49%-58.21%-25.23B-1.44B-16.43
FY201931 Dec 201938.95B+615.94%99.75%40.77B-1.83B23.75
FY201831 Dec 20185.44B—14.42%7.31B-1.87B3.13
FY201731 Dec 2017-6.13B-623.83%-17.11%-4.51B-1.63B-3.37
FY201631 Dec 20161.17B-49.11%3.58%2.45B-1.28B0.62
FY201531 Dec 20152.30B+1,555.40%6.92%3.67B-1.37B1.18
FY201431 Dec 2014139.00M-99.59%0.43%1.13B-992.00M0.07
FY201331 Dec 201333.69B+43.70%109.46%35.01B-1.32B17.22
FY201231 Dec 201223.45B+66.55%95.15%24.76B-1.31B12.22
FY201131 Dec 201114.08B-64.28%46.02%15.38B-1.30B8.40
FY201031 Dec 201039.41B—134.24%40.61B-1.20B27.93
FY200931 Dec 2009-48.83B-167.80%-226.07%-45.95B-2.88B-41.19
FY200831 Dec 200872.02B—407.75%73.42B-1.40B65.73
FY200730 Nov 2007-23.56B—-94.30%-22.09B-1.47B-22.35
FY200630 Nov 2006-60.80B—-213.39%-60.80B0.00-57.64
FY200530 Nov 2005-31.89B—-140.45%-31.35B-540.00M-29.53
FY200430 Nov 2004-25.08B-1,531.22%-105.79%-24.51B-569.00M-22.69
FY200330 Nov 20031.75B—7.92%2.36B-603.00M1.59
FY200230 Nov 2002-6.18B—-30.22%-5.05B-1.12B-5.56
FY200130 Nov 2001-26.09B—-112.96%-24.09B-2.00B-23.26
FY200030 Nov 2000-3.22B—-11.96%-2.38B-836.00M-2.81
FY199930 Nov 1999-29.93B-294.72%-135.59%-29.27B-656.00M-25.81
FY199830 Nov 199815.37B—87.24%15.37B0.0012.67
FY199730 Nov 1997-889.00M-140.26%-5.45%-588.00M-301.00M-0.73
FY199631 Dec 19962.21B+49.54%29.59%2.21B0.003.49
FY199531 Dec 19951.48B-48.97%23.00%1.48B0.001.95
FY199431 Dec 19942.89B+114.28%52.11%2.89B0.003.79
FY199331 Dec 19931.35B-71.46%26.98%1.35B0.002.46
FY199231 Jan 19934.73B—318.25%4.80B-66.30M29.13
FY199131 Dec 1991-2.97B—-234.53%-2.76B-211.40M-18.66
FY199031 Dec 1990-4.84B—-451.93%-4.68B-165.30M-32.68
FY198931 Dec 1989-8.53B—-644.10%-8.46B-70.60M-56.46

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Morgan Stanley's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.